[1]
|
Digklia, A. and Wagner, A.D. (2016) Advanced Gastric Cancer: Current Treatment Landscape and Future Perspectives. World Journal of Gastroenterology, 22, 2403-2414. https://doi.org/10.3748/wjg.v22.i8.2403
|
[2]
|
Parkin, D.M., Bray, F., Ferlay, J. and Pisani, P. (2005) Global Cancer Statistics, 2002. CA: A Cancer Journal for Clinicians, 55, 74-108. https://doi.org/10.3322/canjclin.55.2.74
|
[3]
|
Shimada, H., Noie, T., Ohashi, M., Oba, K. and Takahashi, Y. (2014) Clinical Significance of Serum Tumor Markers for Gastric Cancer: A Systematic Review of Literature by the Task Force of the Japanese Gastric Cancer Association. Gastric Cancer, 17, 26-33. https://doi.org/10.1007/s10120-013-0259-5
|
[4]
|
Zhou, Y., Liepe, J., Sheng, X., Stumpf, M.P. and Barnes, C. (2011) GPU Accelerated Biochemical Network Simulation. Bioinformatics, 27, 874-876. https://doi.org/10.1093/bioinformatics/btr015
|
[5]
|
Nobile, M.S., Cazzaniga, P., Tangherloni, A. and Besozzi, D. (2017) Graphics Processing Units in Bioinformatics, Computational Biology and Systems Biology. Briefings in Bioinformatics, 18, 870-885.
https://doi.org/10.1093/bib/bbw058
|
[6]
|
Chaudhary, K., Poirion, O.B., Lu, L. and Garmire, L.X. (2018) Deep Learning-Based Multi-Omics Integration Robustly Predicts Survival in Liver Cancer. Clinical Cancer Research, 24, 1248-1259.
https://doi.org/10.1158/1078-0432.CCR-17-0853
|
[7]
|
Qiu, Z., Li, H., Zhang, Z., et al. (2019) A Pharmacogenomic Landscape in Human Liver Cancers. Cancer Cell, 36, 179-193.e11. https://doi.org/10.1016/j.ccell.2019.07.001
|
[8]
|
Hoshi, H. (2020) Management of Gastric Adenocarcinoma for General Surgeons. Surgical Clinics of North America, 100, 523-534. https://doi.org/10.1016/j.suc.2020.02.004
|
[9]
|
Wadhwa, R., Song, S., Lee, J.S., Yao, Y., Wei, Q. and Ajani, J.A. (2013) Gastric Cancer-Molecular and Clinical Dimensions. Nature Reviews Clinical Oncology, 10, 643-655. https://doi.org/10.1038/nrclinonc.2013.170
|
[10]
|
Song, S. and Ajani, J.A. (2013) The Role of microRNAs in Cancers of the Upper Gastrointestinal Tract. Nature Reviews Gastroenterology & Hepatology, 10, 109-118. https://doi.org/10.1038/nrgastro.2012.210
|
[11]
|
Mongan, A.M., Kalachand, R., King, S., et al. (2015) Outcomes in Gastric and Junctional Cancer Using Neoadjuvant and Adjuvant Chemotherapy (Epirubicin, Oxaliplatin, and Capecitabine) and Radical Surgery. Irish Journal of Medical Science, 184, 417-423. https://doi.org/10.1007/s11845-014-1135-y
|
[12]
|
Karimi, P., Islami, F., Anandasabapathy, S., Freedman, N.D. and Kamangar, F. (2014) Gastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention. Cancer Epidemiology, Biomarkers & Prevention, 23, 700-713.
https://doi.org/10.1158/1055-9965.EPI-13-1057
|
[13]
|
Cao, W., Zhou, D., Tang, W., An, H. and Zhang, Y. (2019) Discovery of Plasma Messenger RNA as Novel Biomarker for Gastric Cancer Identified through Bioinformatics Analysis and Clinical Validation. PeerJ, 7, e7025.
https://doi.org/10.7717/peerj.7025
|
[14]
|
Wang, X., Liu, Z., Tong, H., et al. (2019) Linc01194 Acts as an Oncogene in Colorectal Carcinoma and Is Associated with Poor Survival Outcome. Cancer Management and Research, 11, 2349-2362.
https://doi.org/10.2147/CMAR.S189189
|
[15]
|
Meuwissen, M.E., Halley, D.J., et al. (2015) The Expanding Phenotype of COL4A1 and COL4A2 Mutations: Clinical Data on 13 Newly Identified Families and a Review of the Literature. Genetics in Medicine, 17, 843-853.
https://doi.org/10.1038/gim.2014.210
|
[16]
|
Jin, R., Shen, J., Zhang, T., et al. (2017) The Highly Expressed COL4A1 Genes Contributes to the Proliferation and Migration of the Invasive Ductal Carcinomas. Oncotarget, 8, 58172-58183. https://doi.org/10.18632/oncotarget.17345
|
[17]
|
Miyake, M., Hori, S., Morizawa, Y., et al. (2017) Collagen Type IV Alpha 1 (COL4A1) and Collagen Type XIII Alpha 1 (COL13A1) Produced in Cancer Cells Promote Tumor Budding at the Invasion Front in Human Urothelial Carcinoma of the Bladder. Oncotarget, 8, 36099-36114. https://doi.org/10.18632/oncotarget.16432
|
[18]
|
Miyake, M., Morizawa, Y., et al. (2017) Diagnostic and Prognostic Role of Urinary Collagens in Primary Human Bladder Cancer. Cancer Science, 108, 2221-2228. https://doi.org/10.1111/cas.13384
|
[19]
|
Huang, R., Gu, W., Sun, B. and Gao, L. (2018) Identification of COL4A1 as a Potential Gene Conferring Trastuzumab Resistance in Gastric Cancer Based on Bioinformatics Analysis. Molecular Medicine Reports, 17, 6387-6396.
https://doi.org/10.3892/mmr.2018.8664
|
[20]
|
Li, T., Gao, X., Han, L., Yu, J. and Li, H. (2018) Identification of Hub Genes with Prognostic Values in Gastric Cancer by Bioinformatics Analysis. World Journal of Surgical Oncology, 16, 114. https://doi.org/10.1186/s12957-018-1409-3
|
[21]
|
Cao, L., Chen, Y., Zhang, M., et al. (2018) Identification of Hub Genes and Potential Molecular Mechanisms in Gastric Cancer by Integrated Bioinformatics Analysis. PeerJ, 6, e5180. https://doi.org/10.7717/peerj.5180
|
[22]
|
Lee, S.Y., Kim, D.Y., Kyung, K.M., et al. (2019) High Circulating Follistatin-Like Protein 1 as a Biomarker of a Metabolically Unhealthy State. Endocrine Journal, 66, 241-251. https://doi.org/10.1507/endocrj.EJ18-0352
|
[23]
|
Wu, J., Dong, Y., Teng, X., Cheng, M., Shen, Z. and Chen, W. (2015) Follistatin-Like 1 Attenuates Differentiation and Survival of Erythroid Cells through Smad2/3 Signaling. Biochemical and Biophysical Research Communications, 466, 711-716. https://doi.org/10.1016/j.bbrc.2015.09.044
|
[24]
|
Bae, K., Park, K.E., Han, J., Kim, J., Kim, K. and Yoon, K.A. (2016) Mitotic Cell Death Caused by Follistatin-Like 1 Inhibition Is Associated with Up-Regulated Bim by Inactivated Erk1/2 in Human Lung Cancer Cells. Oncotarget, 7, 18076-18084. https://doi.org/10.18632/oncotarget.6729
|
[25]
|
Chan, Q.K., Ngan, H.Y., Ip, P.P., Liu, V.W., Xue, W.C. and Cheung, A.N. (2009) Tumor Suppressor Effect of Follistatin-Like 1 in Ovarian and Endometrial Carcinogenesis: A Differential Expression and Functional Analysis. Carcinogenesis, 30, 114-121. https://doi.org/10.1093/carcin/bgn215
|
[26]
|
Zhang, Y., Xu, X., Yang, Y., et al. (2018) Deficiency of Follistatin-Like Protein 1 Accelerates the Growth of Breast Cancer Cells at Lung Metastatic Sites. Journal of Breast Cancer, 21, 267-276. https://doi.org/10.4048/jbc.2018.21.e43
|
[27]
|
Massagué, J. (2008) TGFbeta in Cancer. Cell, 134, 215-230. https://doi.org/10.1016/j.cell.2008.07.001
|
[28]
|
Termine, J.D., Kleinman, H.K., Whitson, S.W., Conn, K.M., McGarvey, M.L. and Martin, G.R. (1981) Osteonectin, a Bone-Specific Protein Linking Mineral to Collagen. Cell, 26, 99-105. https://doi.org/10.1016/0092-8674(81)90037-4
|
[29]
|
Feng, J. and Tang, L. (2014) SPARC in Tumor Pathophysiology and as a Potential Therapeutic Target. Current Pharmaceutical Design, 20, 6182-6190. https://doi.org/10.2174/1381612820666140619123255
|
[30]
|
Nagaraju, G.P., Dontula, R., El-Rayes, B.F. and Lakka, S.S. (2014) Molecular Mechanisms Underlying the Divergent Roles of SPARC in Human Carcinogenesis. Carcinogenesis, 35, 967-973. https://doi.org/10.1093/carcin/bgu072
|
[31]
|
Sato, T., Oshima, T., Yamamoto, N., et al. (2013) Clinical Significance of SPARC Gene Expression in Patients with Gastric Cancer. Journal of Surgical Oncology, 108, 364-368. https://doi.org/10.1002/jso.23425
|
[32]
|
Chen, J., Wang, M., Xi, B., et al. (2012) SPARC Is a Key Regulator of Proliferation, Apoptosis and Invasion in Human Ovarian Cancer. PLoS ONE, 7, e42413. https://doi.org/10.1371/journal.pone.0042413
|
[33]
|
Chew, A., Salama, P., Robbshaw, A., et al. (2011) SPARC, FOXP3, CD8 and CD45 Correlation with Disease Recurrence and Long-Term Disease-Free Survival in Colorectal Cancer. PLoS ONE, 6, e22047.
https://doi.org/10.1371/journal.pone.0022047
|
[34]
|
Liang, J.F., Wang, H.K., Xiao, H., et al. (2010) Relationship and Prognostic Significance of SPARC and VEGF Protein Expression in Colon Cancer. Journal of Experimental & Clinical Cancer Research, 29, 71.
https://doi.org/10.1186/1756-9966-29-71
|